DNDi

GARDP and Penta partner to accelerate the development of children’s antibiotics to tackle AMR

2019

Penta have joined forces with GARDP (The Global Antibiotic Research & Development Partnership) to tackle drug-resistant infections in children. Our strategic collaboration aims to accelerate paediatric development of antibiotic treatments including: clinical trials designed to meet regulatory requirements;

Read More